Molecular Sensing Inc. has received Phase I and Phase II research grant awards from the National Institutes of Health to support research and development of the company’s technology. Click here to see the company’s policy for maintaining Research Integrity Policy and avoiding Research Conflict of Interest.
Contact MSI to further discuss our NIH grant support.
Visit our booth #1619 and attend our Tuesday Tutorial on Conformation-Sensitive Assay Detection for Accelerated Drug Discovery Research. Learn about the superior analytical power of TruBind™ Back Scattering Interferometry (BSI) technology for molecular interaction studies.
TRY A LOW-RISK, HIGH-RETURN DRUG DISCOVERY PROJECT
Take advantage of our success-based drug-target characterization services including ortho- and allosteric membrane bound proteins, receptors, ion channels, protein complexes — your toughest targets.
